
via Harvard Health
Researchers at LSU Health New Orleans Neuroscience Center of Excellence and colleagues have discovered a new class of pipeline drugs to relieve pain and reduce fever without the danger of addiction or damage to the liver or kidneys. The research is published online in the European Journal of Medicinal Chemistry.
Current drugs have unwanted side effects. Opioids can not only cause addiction; recent studies have shown they can be no more effective at relieving pain than non-narcotic drugs. Non-steroidal anti-inflammatories (NSAIDs) can cause kidney damage. Acetaminophen is an effective drug, but overuse can result in liver damage.
The research team, led by Drs. Hernan A. Bazan, a professor in the Department of Surgery and Program Director of the Vascular Surgery Fellowship at Ochsner Clinic, and Surjyadipta Bhattacharjee, a post-doctoral researcher at the LSU Health New Orleans Neuroscience Center of Excellence, set out to discover what causes the liver damage associated with acetaminophen and then create a drug structurally similar to acetaminophen — as effective, but without liver toxicity. Along with the chemistry team led by Professor Julio Alvarez-Builla, Department of Organic Chemistry at the University of Alcala in Madrid, they tested 21 different compounds as acetaminophen analogs.
Senior author Nicolas Bazan, MD, PhD, Boyd Professor and Director of LSU Health New Orleans Neuroscience Center of Excellence says, “The new chemical entities reduced pain in two in models without the liver and kidney toxicity associated with current over-the-counter analgesics that are commonly used to treat pain — acetaminophen and NSAIDs. They also reduced fever in a pyretic model. This is particularly important in the search for an antipyretic with a safer profile in the COVID-19 pandemic and its associated kidney and liver disease in critically ill SARS-CoV-2 patients.”
Acute and chronic pain management is one of the most prevalent and costly public health issues worldwide. According to the Centers for Disease Control and Prevention, an estimated 50 million — 20.4% of U.S. adults had chronic pain and 8.0% of U.S. adults had high-impact chronic pain in 2016.
“Given the widespread use of acetaminophen, the risk of hepatotoxicity with overuse, and the ongoing opioid epidemic, these new chemical entities represent novel, non-narcotic analgesics that exclude hepatotoxicity, for which development may lead to safer treatment of acute and chronic pain and fever,” adds Dr. Nicolas Bazan.
The intellectual property behind these new technologies, which are part of this discovery, have been licensed from LSU Health Sciences Center New Orleans to the life science startup South Rampart Pharma, LLC that is currently developing this new drug in late pre-clinical stages.
“Our primary goal is to develop and commercialize new alternative pain medications that lack abuse potential and have fewer associated safety concerns than current treatment options, and this peer-reviewed paper describes the discovery of the initial library of compounds as well as several proof of concept animal and molecular studies,” says Dr. Hernan Bazan.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Acute and chronic pain management
- Is Chronic Pelvic Pain Ruining Your Sex Life?
I have seen firsthand how real lives are turned upside down as patients grapple with symptoms they're often too shy to address.
- Pain management physician comes to Uniontown
WVU Medicine Uniontown Hospital announced the addition of Spring McCann, MD, to the team as its newest pain management physician.
- Systematic Review of Dexketoprofen in Acute and Chronic Pain
Background: Dexketoprofen, an NSAID used in the management of acute and chronic ... Results: Thirty-five trials were found in acute pain and chronic pain; 6,380 patients were included, 3,381 ...
- Connection Between Pain And High Blood Pressure: Expert Explains How Pain Can Cause High Blood Pressure
Acute and chronic pain can elevate your blood pressure levels and lead to symptoms like muscle tension and stress.
- Virtual Reality for Pain Management
Virtual reality (VR) is an emerging rehabilitation technology that has been employed in the management of acute and chronic pain of various origin. It is a promising effective intervention for ...
Go deeper with Google Headlines on:
Acute and chronic pain management
[google_news title=”” keyword=”Acute and chronic pain management” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Alternative pain medications
- The Overlooked Tyranny of Quick Fixes
Many people prefer certain psychiatric medications (or related quick fixes) over learning how to cope with and overcome a problem naturally through psychotherapy or learning long-term changes in ...
- Nephron faces lawsuit over pain med competitor says it sold without FDA approval
A competing pharmaceutical company is suing SC’s Nephron over drugs it says the company sold without FDA approval, undercutting its own medication on the market.
- Top 6 Best OTC Arthritis Supplements in 2023
If you’re looking for a natural alternative to traditional pain relief medication, T-Relief Arthritis Arnica +12 Natural Pain Medicines might be worth considering. The formula contains 13 ...
- ADHD Medications for Children: What to Know
Attention deficit hyperactivity disorder (ADHD) is a commonly diagnosed neurological condition. It affects more than 8% of children and 2.5% of adults. In children, ADHD can impact many aspects of ...
- Palmitoylethanolamide: A Natural Alternative For Chronic Pain And Inflammation
Are you seeking a natural remedy for chronic pain and inflammation? Look no further than Palmitoylethanolamide, a powerf ...
Go deeper with Google Headlines on:
Alternative pain medications
[google_news title=”” keyword=”alternative pain medications” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]